Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors

Lucia Regales, Marissa N. Balak, Yixuan Gong et al. · 2007

Read Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors by Lucia Regales, Marissa N. Balak, Yixuan Gong et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000810.txt.

Description

Lucia Regales, Marissa N. Balak, Yixuan Gong and colleagues built mice whose lung tumors carry a drug-resistance mutation, for PLOS ONE in 2007. The EGFR T790M mutation confers acquired resistance to kinase inhibitors in human lung adenocarcinoma with EGFR mutations. It is occasionally detected before treatment, and may also confer genetic susceptibility to lung cancer. Studying its role in tumor formation needed a living model.

The team developed mice with lung tumors expressing the T790M mutant. Such models let researchers watch resistance arise, and test next-generation inhibitors against it in a whole animal. Lung cancer drugs often fail exactly at this mutation, so a faithful model is strategic ground for drug development.

Catalog record

CREATORLucia Regales, Marissa N. Balak, Yixuan Gong et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000810

Browse the full library · About the Tower of Babel